Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

Author： Li Sophia   Kaur Primal   Chan Virginia   Berney Steven  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.28, Iss.7, 2009-07, pp. : 787-791

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inhibition of tumour necrosis factor-α in patients with chronic hepatitis C infection

By Zavos C.   Kountouras J.   Zavos N.   Chatzopoulos D.  

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 283-283

Springer Publishing Company

Access to resources Recommend Favorite

Association Between Polymorphism of Tumor Necrosis Factor-α Promoter and Response to Lamivudine Treatment in Patients with Chronic Hepatitis B

By Park Yong   Lee Jung   Kim Do   Chang Hye   Kim Ja   Lee Chun   Park Jun   Ahn Sang   Lee Kwan   Han Kwang  

Digestive Diseases and Sciences, Vol. 55, Iss. 7, 2010-07 ,pp. : 2043-2048

Springer Publishing Company

Access to resources Recommend Favorite

Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action

By Carroll Matthew   Forgione Michael  

Clinical Rheumatology, Vol. 29, Iss. 9, 2010-09 ,pp. : 1021-1029

Springer Publishing Company

Access to resources Recommend Favorite

A systematic review of the effect of TNF-α antagonists on lipid profiles in patients with rheumatoid arthritis

By Pollono Eduardo   Lopez-Olivo Maria   Lopez Juan   Suarez-Almazor Maria  

Clinical Rheumatology, Vol. 29, Iss. 9, 2010-09 ,pp. : 947-955

Springer Publishing Company

Access to resources Recommend Favorite

Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α

By Onishi Sachiko   Yoshio Taku   Nagashima Takao   Minota Seiji  

Modern Rheumatology, Vol. 20, Iss. 5, 2010-10 ,pp. : 528-530

Springer Publishing Company

Access to resources Recommend Favorite